Jadwal Sholat

Memuat jadwal sholatโ€ฆ

Kedokteran & Kesehatan editorial

Open AccessOA2023

A Framework for Assessing Clinical Trial Site Readiness

Clinical trial experts developed a six-domain framework for site readiness to reduce inefficiencies and costs in trial conduct, and to help new sites enter the clinical trials enterprise, potentially improving access for underserved communities.
J. Buse; Chris P. Austin; S. C. Johnston; F. Lewis-Hall; Andrew N. March; Carolyn K. Shore; P. Tenaerts; J. Rutterยท Journal of Clinical and Translational Scienceยท 2023ยท DOI 10.1017/cts.2023.541

The core problem

Clinical trial processes are unnecessarily inefficient and costly, which slows the translation of medical discoveries into treatments for people living with disease. To address these redundancies and inefficiencies, a group of clinical trial experts developed a framework for clinical trial site readiness. The framework is based on existing trial site qualifications from sponsors and aims to streamline trial conduct and facilitate the entry of new sites into the clinical trials enterprise. The authors note that implementation of this framework could improve the reach of clinical trials to underserved communities. The framework holds benefits for trial sponsors, contract research organizations, trade associations, trial participants, and the public. For novice sites, it provides a structure for site preparation and stakeholder engagement; for experienced sites, it can be used to assess current practices and inform and engage sponsors, staff, and participants. Supplementary materials provide access to key regulatory documents and resources, and invited perspective articles offer greater depth from systems, DEIA (diversity, equity, inclusion, and accessibility), and decentralized trials perspectives.

Innovation

The framework was developed by a group of clinical trial experts based on existing trial site qualifications from sponsors. The authors do not detail the specific consensus process in the abstract, but the framework encompasses six domains: research team, infrastructure, study management, data collection and management, quality oversight, and ethics and safety. These domains represent key areas that trial sites must address to be ready for clinical trials. The development process likely involved reviewing existing sponsor qualifications and synthesizing them into a comprehensive framework. The framework is intended to be applicable to both novice and experienced sites, with supplementary materials providing easy access to key regulatory documents and resources. Invited perspective articles provide additional depth from systems, DEIA, and decentralized trials perspectives.
Introduction
Clinical trial processes are unnecessarily inefficient and costly, which slows the translation of medical discoveries into treatments for people living with disease. To address these redundancies and inefficiencies, a group of clinical trial experts developed a framework for clinical trial site readiness. The framework is based on existing trial site qualifications from sponsors and aims to streamline trial conduct and facilitate the entry of new sites into the clinical trials enterprise. The authors note that implementation of this framework could improve the reach of clinical trials to underserved communities. The framework holds benefits for trial sponsors, contract research organizations, trade associations, trial participants, and the public. For novice sites, it provides a structure for site preparation and stakeholder engagement; for experienced sites, it can be used to assess current practices and inform and engage sponsors, staff, and participants. Supplementary materials provide access to key regulatory documents and resources, and invited perspective articles offer greater depth from systems, DEIA (diversity, equity, inclusion, and accessibility), and decentralized trials perspectives.

Why it matters

The authors discuss the implications of the framework for various stakeholders. They emphasize that the framework can reduce redundancies and inefficiencies in clinical trial processes, which are currently costly and slow. By providing a structured approach to site readiness, the framework can help new sites prepare for trials and enable experienced sites to assess and improve their practices. The inclusion of DEIA and decentralized trials perspectives in invited articles suggests that the framework is adaptable to modern trial designs and diverse populations. The framework's potential to improve access for underserved communities is highlighted as a key benefit. The authors also note that the framework can facilitate engagement with sponsors, staff, and participants. Overall, the framework is presented as a tool to enhance the efficiency and reach of clinical trials, with benefits for multiple stakeholders across the clinical trials enterprise.

Who should read this

Pembaca Research Digest dan praktisi rumpun ini.

Opening member contentโ€ฆ